Skip to main content
. 2012 Apr 4;102(7):1543–1550. doi: 10.1016/j.bpj.2012.01.042

Figure 4.

Figure 4

Shift in cluster lifetimes is transient for Latrunculin. (A) Lifetime of MHC-I clusters from cells incubated with 200 nM Latrunculin (identical with Fig. 2, top panel) imaged immediately after removing the drug. (B) Lifetime of MHC-I clusters from same cells, 30 min after removing the drug. (C) Lifetime of MHC-I clusters from untreated cells. (Solid lines) Fit to log-normal distribution. (Vertical dashed line) Mode (peak) of the distribution for 200 nM Latrunculin treatment. (Arrows) Gradual shift toward longer lifetimes, as the effect of Latrunculin is reduced.